EUVIMEDEUVIMED entdecken
Crossref

Pharmacist–Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy

Masaki Hirabatake, Hiroaki Ikesue, Shintaro Yoshino, Mayu Morimoto, Toshinari Yamasaki, Tohru Hashida, Mutsushi Kawakita, Nobuyuki Muroi

Biological and Pharmaceutical Bulletin · 2023

DOI: 10.1248/bpb.b22-00917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Masaki Hirabatake und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kobe City Medical Center General Hospital. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansPharmacistsUrologistsRetrospective StudiesTreatment OutcomeIndazolesAngiogenesis InhibitorsPyrimidinesSulfonamides

Stichwörter der Autor:innen

ambulatory carecollaborative managementpazopanibpharmacistrenal cell carcinoma

Substanzen

IndazolesAngiogenesis InhibitorspazopanibPyrimidinesSulfonamides

Autor:innen und Institutionen

  • Department of Pharmacy, Kobe City Medical Center General Hospital.
  • Department of Urology, Kobe City Medical Center General Hospital.
  • Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University.

Zitieren

APA

Hirabatake, M., Ikesue, H., Yoshino, S., Morimoto, M., Yamasaki, T., Hashida, T., Kawakita, M., & Muroi, N. (2023). Pharmacist–Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b22-00917

Vancouver

Hirabatake M, Ikesue H, Yoshino S, Morimoto M, Yamasaki T, Hashida T, et al. Pharmacist–Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b22-00917

BibTeX
@article{Hirabatake2023,
  author = {Hirabatake, Masaki and Ikesue, Hiroaki and Yoshino, Shintaro and Morimoto, Mayu and Yamasaki, Toshinari and Hashida, Tohru and Kawakita, Mutsushi and Muroi, Nobuyuki},
  title = {Pharmacist–Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2023},
  doi = {10.1248/bpb.b22-00917}
}
Kostenlos starten →